Literature DB >> 32484887

Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.

Julien Favresse1,2, Christine Eucher1, Marc Elsen1, Marie Tré-Hardy2,3,4, Jean-Michel Dogné2, Jonathan Douxfils2,5.   

Abstract

Keywords:  COVID-19; SARS-CoV-2; kinetics; serology

Mesh：

Substances：

Year:  2020        PMID： 32484887      PMCID： PMC7314109          DOI： 10.1093/clinchem/hvaa131

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  27 in total

1.  Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2.

Authors:  Raymond T Suhandynata; Melissa A Hoffman; Deli Huang; Jenny T Tran; Michael J Kelner; Sharon L Reed; Ronald W McLawhon; James E Voss; David Nemazee; Robert L Fitzgerald
Journal:  Clin Chem       Date:  2021-01-30       Impact factor: 8.327

2.  SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

Authors:  Marie-Luise Buchholtz; Florian M Arend; Peter Eichhorn; Michael Weigand; Alisa Kleinhempel; Kurt Häusler; Mathias Bruegel; Lesca M Holdt; Daniel Teupser
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

3.  Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

Authors:  C van Marcke; N Honoré; A van der Elst; S Beyaert; F Derouane; C Dumont; F Aboubakar Nana; J F Baurain; I Borbath; P Collard; F Cornélis; A De Cuyper; F P Duhoux; B Filleul; R Galot; M Gizzi; F Mazzeo; T Pieters; E Seront; I Sinapi; M Van den Eynde; N Whenham; J C Yombi; A Scohy; A van Maanen; J P Machiels
Journal:  BMC Cancer       Date:  2021-05-20       Impact factor: 4.430

4.  Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital.

Authors:  Emmanuel Vivier; Caroline Pariset; Stephane Rio; Sophie Armand; Fanny Doroszewski; Delphine Richard; Marc Chardon; Georges Romero; Pierre Metral; Matthieu Pecquet; Adrien Didelot
Journal:  Ann Intensive Care       Date:  2021-05-13       Impact factor: 6.925

5.  Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.

Authors:  Catherine Riou; Elsa du Bruyn; Cari Stek; Remy Daroowala; Rene T Goliath; Fatima Abrahams; Qonita Said-Hartley; Brian W Allwood; Nei-Yuan Hsiao; Katalin A Wilkinson; Cecilia S Lindestam Arlehamn; Alessandro Sette; Sean Wasserman; Robert J Wilkinson
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

6.  Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2.

Authors:  Jean-Louis Bayart; Laure Morimont; Mélanie Closset; Grégoire Wieërs; Tatiana Roy; Vincent Gerin; Marc Elsen; Christine Eucher; Sandrine Van Eeckhoudt; Nathalie Ausselet; Clara David; François Mullier; Jean-Michel Dogné; Julien Favresse; Jonathan Douxfils
Journal:  Microorganisms       Date:  2021-06-21

7.  Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.

Authors:  Catherine Riou; Georgia Schäfer; Elsa du Bruyn; Rene T Goliath; Cari Stek; Huihui Mou; Deli Hung; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671

8.  Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.

Authors:  Julien Favresse; Christine Eucher; Marc Elsen; Carlos Graux; Paul Goebels; Kim Laffineur; Jean-Baptiste Nicolas; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Br J Haematol       Date:  2020-07-09       Impact factor: 8.615

9.  High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.

Authors:  Antoine Mairesse; Julien Favresse; Christine Eucher; Marc Elsen; Marie Tré-Hardy; Caroline Haventith; Damien Gruson; Jean-Michel Dogné; Jonathan Douxfils; Paul Göbbels
Journal:  Clin Biochem       Date:  2020-08-25       Impact factor: 3.281

10.  Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.

Authors:  Julien Favresse; Constant Gillot; Laura Di Chiaro; Christine Eucher; Marc Elsen; Sandrine Van Eeckhoudt; Clara David; Laure Morimont; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.